Pubertede koroner revaskülarizasyon ve ailesel hiperlipidemi: Greft seçimi

Familyal hiperlipidemi, çok erken yaşlarda koroner arter hastalığına sebep olabilen malign karakterli nadir bir hastalıktır. Burada plazma kolesterol düzeyleri kontrol altına alınamamış 14 yaşında bir olguyu sunuyoruz. Büyüme potansiyeli ve açık kalma oranları göz önüne alındığında greft seçiminin bu olguda önem gösterdiği ortaya çıkmaktadır. Biz olgumuzda iki adet arteriyel, bir adet de safen ven grefti kullandık.

Abstract

Familial hyperlipidemia is a rare condition with malignant behavior, resulting in premature coronary artery disease. We report a 14 years old case with undertreated plasma cholesterol levels. Graft selection due to growth potential and patency rates was one of the important problems in this patient. Two arterial grafts and one saphenous vein were implanted for coronary revascularization.

🔖

Bu Makaleye Atıf Yap

HAZAN, E., UĞURLU, B., SARIOSMANOĞLU, N., AKÇORAL, A., METİN, K., SAYLAM, G., OTO, Ö., ÜNAL, N. (2022). Pubertede koroner revaskülarizasyon ve ailesel hiperlipidemi: Greft seçimi. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 11 - Sayı: 3, 188–189. https://ajindex.com/articles/425429

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

Demetriou K, H’Maltezou E, Pierides AM. Familial homozygous hypercholesterolemia: Effective long-term treatment with cascade double filtration plasmapheresis. Blood Purif 2001;19:308-13. 2. Voors-Pette C, de Bruin TW. Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity. Atherosclerosis 2001;157:481-9. 3. Real JT, Chaves FJ, Martinez-Uso I, Garcia-Garcia AB, Ascaso JF, Carmena R. Importance of HDL cholesterol levels and the total/HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolemia. Eur Heart J 2001;22:465-71. 4. Stehbens WE. Coronary heart disease, hypercholesterolemia, and atherosclerosis. I. False premises. Exp Mol Pathol 2001;70:103-19. 5. Kawasuji M, Sakakibara N, Fujii S,Yasuda T, Watanabe Y. Coronary artery bypass surgery with arterial grafts in familial hypercholesterolemia. J Thorac Cardiovasc Surg 2000;119:1008-13. 6. Kawasuji M, Sakakibara N, Takemura H, Matsumoto Y, Mabuchi H, Watanabe Y. Coronary artery bypass grafting in familial hypercholesterolemia. J Thorac Cardiovasc Surg 1995;109:364-9. 7. Yoshikawa Y, Yagihara T, Kameda Y, et al. Result of surgical treatments in patients with coronary-arterial obstructive disease after Kawasaki disease. Eur J Cardiothorac Surg 2000;17:515-9.